Sample Collection
Sample Collection is an intervention with 65 clinical trials. Currently 21 active trials ongoing. Historical success rate of 89.3%.
Success Metrics
Based on 25 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.2%
25 of 29 finished
13.8%
4 ended early
21
trials recruiting
65
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Oral Microbiome in Carotid Atherosclerosis
iSITE: Investigation of Somatic Alterations in Tumours of the Eye
Diabetes Reversal and the Subgingival Microbiota
Observational Study of Exposure to Environmental Toxicants Among Firefighters
Omics of Rituximab-resistance
Clinical Trials (65)
Oral Microbiome in Carotid Atherosclerosis
iSITE: Investigation of Somatic Alterations in Tumours of the Eye
Diabetes Reversal and the Subgingival Microbiota
Observational Study of Exposure to Environmental Toxicants Among Firefighters
Omics of Rituximab-resistance
Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario
A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients
Exosome Cargo From Preeclampsia Patients
Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19
Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Cancer
Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
Combinatorial Single Cell Strategies for a Crohn's Disease Gut Cell Atlas
SMS - Study of Somatic Mutations Using Genome Sequencing
Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone
CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2
The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)
Johns Hopkins Breast Cancer Program Longitudinal Repository
Longitudinal Oral Microbiome Sampling for BE
Advancing Prevention of Pulmonary Fibrosis
Biomarker Identification for Bladder Cancer Patients
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 65